293 related articles for article (PubMed ID: 35868004)
1. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
Ogutmen Koc D; Bektas S
Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
[TBL] [Abstract][Full Text] [Related]
4. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
[TBL] [Abstract][Full Text] [Related]
5. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
6. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
7. [A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].
Wang XT; Ji ZZ; Han F; Lyu B
Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):227-232. PubMed ID: 33663171
[No Abstract] [Full Text] [Related]
8. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
9. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
10.
Wu M; Feng S; Qian M; Wang S; Zhang K
Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
[TBL] [Abstract][Full Text] [Related]
11. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
12. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
[TBL] [Abstract][Full Text] [Related]
13. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.
Tong Y; Wu Y; Song Z; Yu Y; Yu X
BMC Gastroenterol; 2017 Jul; 17(1):88. PubMed ID: 28728545
[TBL] [Abstract][Full Text] [Related]
14. Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population.
Cai HL; Tong YL
World J Clin Cases; 2021 Nov; 9(31):9431-9439. PubMed ID: 34877278
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract][Full Text] [Related]
16. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications.
Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
[TBL] [Abstract][Full Text] [Related]
18. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
[TBL] [Abstract][Full Text] [Related]
19. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
20. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]